Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
Main Authors: | Zuo, Yufang, Wu, Jiangxue, Xu, Zumin, Yang, Shiping, Yan, Haijiao, Tan, Li, Meng, Xiangqi, Ying, Xiaofang, Liu, Ranyi, Kang, Tiebang, Huang, Wenlin |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088667/ |
Similar Items
-
Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
by: Yu, Hongyan, et al.
Published: (2013) -
Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 – new vectors for in vitro and in vivo delivery
by: Magin-Lachmann, Christine, et al.
Published: (2003) -
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
by: Fang, Wenfeng, et al.
Published: (2014) -
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
by: Drozd, Anna M., et al.
Published: (2015) -
HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus
by: Dheekollu, Jayaraju, et al.
Published: (2016)